BE of Euthyrox® Tablets (Merck Nantong Versus Merck Darmstadt Sites)
Clinical trial NCT05174000 · COMPLETED
Trial details
- NCT number
- NCT05174000
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2022-10-18
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.